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ABSTRACT 
Methyl Sulphonyl methane (MSM) is an organ sulfur compound with the formula (CH3)2SO2. Glucosamine is naturally hygroscopic is nature 
when exposed to air and moisture and degradable whether in the form of tablet or raw material.  To overcome this problem Glucosamine needs 
to bond with suitable stabilizer.  Glucosamine Sulphate in the form of Salt i.e. Sodium chloride and potassium chloride are stable. The normal 
dose of Glucosamine is 500-1500 mg TID.  It is very difficult to compress the tablet at the label claim 1500 mg because some additives are also 
required in the formulation and the average weight is 1800 mg.  As per the pre formulation studies it is concluded that tablet average weight 
less than 70 mg are very difficult to compress and more than 1500 mg are difficult to swallow in adult patient.  Glucosamine stimulates the 
formation or manufacture of collagen, the protein portion of the fibrous substance that holds joints together and provides a shock-absorbing 
cushion, as a person ages, the cartilage that cushions the joints often loses its ability to support healthy cellular growth.  This condition, called 
osteoarthritis, often leads to rough bones that rub together and cause distress with every twist or bend.  In this condition patient regularly 
required the Glucosamine tablet in 1500 mg three times a day. But it’s very difficult to compress the tablet at huge weight because D tooling 
compression machine have maximum limit is 1500 mg. For such critical formulation weight cam is adjusted in lower direction to increase the 
weight and feeding of granules in feed frame through force feeder resolve the dissolution problem. This tablet is prepared by wet granulation 
method by using Non Aqueous binding showed good results physical evaluation parameters and chemical parameters such as Assay, and 
Dissolution values. The granules are lubricated using suitable lubricants / Glidant / Antiadhrants were good in their flow properties. Assay and 
dissolution studies were conducted by the HPLC method.  
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1. INTRODUCTION: 
Methyl Sulphonyl methane (MSM) is an organo sulfur 
compound with the formula (CH3)2SO2. It is also known by 
several other names including methyl sulphone and dimethyl 
sulphone (DMSO2).[2] This colorless solid features the 
Sulphonyl functional group and is considered relatively inert 
chemically. It occurs naturally in some primitive plants, is 
present in small amounts in many foods and beverages, and 
is marketed as a dietary supplement. It is sometimes used as 
a cutting agent for illicitly manufactured methamphetamine. 
Glucosamine Sulphate Potassium Chloride and Sodium 
chloride are generally used for joint health. Glucosamine 
support the collagen and protein portion of the fibrous 
substance that holds joints together and provides a shock-
absorbing cushion.  As the age of a person increases, the 
cartilage that cushions the joints often loses its ability to 
support healthy cellular growth. Also the synovial fluid 
which lubricates these joints also deteriorates as the age of a 
person increase or weight. This condition, called 
osteoarthritis, often leads to rough bones that rub together 
and cause distress with every twist or bend.  In this condition 
to treat the patient Non-Steroidal anti-inflammatory drugs 
(NSAID) are used.  NSAID May be COX1 or COX2 inhibitor 
destroyed cartilage.  Other side effect in prolong used of 
NSAID are GIT damage, Haemorrhage. Medicinal science 
discovered a nutrients that help in preserving joint tissue 
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and fluids. Glucosamine is a necessary nutrient in the 
production of cartilage and synovial fluid.  
Pure Glucosamine is fully "hygroscopic" and degradable 
when it come in contact to moisture and air. To mask the 
hygroscopic nature of Glucosamine, it needs to be bound to a 
stabilizer to be sold commercially. The sulphate and the HCL 
forms are two of the most common "agents" that 
Glucosamine is bound and shows its stability. After 
Glucosamine is bound, it is stable and will not degrade. These 
are various difficulties and limitations in the formulation of 
Glucosamine formulation. For example, oral forms, such as 
tablets or capsules, require anti-oxidants, such as sodium 
hyposulphite to present in their formulations, which 
blocking the oxidation of the amino group. 
2. MATERIALS:  
2.1 API structure and Properties. 
2.1.1 Glucosamine So4 KCL. 
INN:    No INN has been specifically assigns for glucosamine 
sulphate Potassium Chloride 
Chemical name:  Bis (D Glucose, 2 amino-2 deoxy), Sulphate 
potassium chloride complex 
Appearance: White and almost white crystalline powder. 
Solubility: Freely soluble in water, sparingly soluble in 
methanol and practically in soluble in acetone. 
Category:  Osteoarthritis, Muscle Injury Prevention, 
Osteochondritis; Rheumatoid Arthritis, tendonitis 
Structure: 
 
 
Molecular formula:           (C6H14NO5)2SO4. 2KCL 
Molecular weight:             573.3 g/ mole 
2.1.2 Methyl Sulphonyl Methane  
INN:    No INN has been specifically assigns for Methyl 
Sulphonyl Methane. 
Chemical name:  Dimethyl sulphone 
Appearance: White crystalline solid 
Density:  1.45 g/cm 
Category:  Osteoarthritis, Muscle Injury Prevention, 
Osteochondritis; Rheumatoid Arthritis, tendonitis 
 
Molecular formula:  C2H6O2S        
Molecular weight:    94.13 g·mol−1          
Glucosamine sulphate was obtained as gift samples from 
ZEON LIFESCIENCE LTD, PONTA SAHIB. DIST. SIRMOUR. H.P. 
(India). (Manufactured by. Bio gene Extract Limited. 
Bangalore. Karnataka, and Costal Laboratories. India) 
Methyl Sulphonyl Methane was obtained as gift samples from 
ZEON LIFESCIENCE LTD, PONTA SAHIB.  DIST. SIRMOUR. 
H.P. (India).  
All the remaining Additives / binder/ preservatives/ 
solvent/ film former/  are the free sample from Tirupati 
Medicate limited, Ponta Sahib, Sirmour, H.P. (India)
 
2.2 List of Materials used in the Glucosamine 1500 mg & MSM 200 Tablet. 
 
 
S. No. Ingredients Role Of Ingredients Supplier 
1 Glucosamine SO4 KCL Active Ingredient Zeon life sciences 
 2 Methyl Sulphonyl Methane Active Ingredient 
3 Lactose Filler  
 
 
Tirupati Medicare 
limited, Ponta sahib. 
Dist. Sirmour. 
H.P. 
4 MCCP Filler 
5 Iso Propyl alcohol Solvents 
6 PVP-K 30 Binding agents 
7 Talcum Powder Lubricants 
8 Magnesium Stearate Antiadhrants 
9 Sodium Starch Glycolate Disintegrants 
10 Aerosil Glidant 
11 Insta coat (White) Film forming agent 
12 Iso Propyl alcohol solvent 
13 Methylene Dichloride Solvents 
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2.3 Drug and Excipients Study. 
S. No. Drug+ Excipients Duration (months) Result 
1  Glucosamine + Starch 6 Months Stable 
2 Glucosamine + Talcum 6 Months Stable 
3 Glucosamine + Mag. Stearate 6 Months Stable 
4 Glucosamine +MCCP 6 Months Stable 
5 Glucosamine +Lactose 6 Months Stable 
6 Glucosamine  +CCS 6 Months Stable 
7 Glucosamine + PVP –K 30 6 Months Stable 
8 Glucosamine  +DC starch 6 Months Stable 
9 Glucosamine + SSG 6 Months Stable 
10 Glucosamine + HPMC 6 Months Stable 
11 Methyl Sulphonyl Methane + Starch 6 Months Stable 
12 Methyl Sulphonyl Methane + Talcum 6 Months Stable 
13 MSM + Mag. Stearate 6 Months Stable 
14 Methyl Sulphonyl Methane +MCCP 6 Months Stable 
15 Methyl Sulphonyl Methane +Lactose 6 Months Stable 
16 Methyl Sulphonyl Methane  +CCS 6 Months Stable 
17 Methyl Sulphonyl Methane + PVP –K 30 6 Months Stable 
18 Methyl Sulphonyl Methane +DC starch 6 Months Stable 
19 Methyl Sulphonyl Methane + SSG 6 Months Stable 
20 Methyl Sulphonyl Methane + HPMC 6 Months Stable 
 
2.4 Formulation table. 
Sr. 
no. 
INGREDIENTS C1 
(mg) 
C2 
(mg) 
C3 
(mg) 
C4 
(mg) 
C5 
(mg) 
1 Glucosamine SO4 KCL 1500 1500 1500 1500 1500 
2 MSM 200 200 200 200 200 
2 Lactose 05 08 12 16 20 
3 MCCP 05 08 12 16 20 
6 Iso Propyl alcohol Q.S. Q.S. Q.S. Q.S. Q.S. 
7 PVP-K 30 45 42 39 36 33 
8 Talcum Powder 10 10 10 10 10 
9 Magnesium Stearate 05 05 05 05 05 
10 SSG 12 12 09 06 03 
11 Aerosil 13 10 08 06 04 
 Film coating Materials      
12 Insta coat (White) 35 35 35 35 35 
13 Isopropyl alcohol Q.S Q.S Q.S Q.S Q.S 
14 MDC Q.S. Q.S. Q.S. Q.S. Q.S. 
 Total Weight 1830 mg 1830 mg 1830 mg 1830 mg 1830 mg 
 
3. METHOD OF PREPARATION OF GRANULES AND 
COMPRESSION OF TABLET. 
3.1 Wet Granulation Method. 
Generally the low weight tablet of Glucosamine Sulphate and 
Methyl Sulphonyl Methane formulation in range of 500- 750 
mg are prepared by direct compression method.  But when 
the dose of Glucosamine are more than 1000 mg or 1500 mg, 
then it is very difficult to compress.  In such case wet 
granulation method are used for preparation of Granulation.  
As glucosamine Sulphate are hygroscopic in nature then non 
aqueous solvent are used. For this the formulator used 
Acetone, Isopropyl Alcohol, or methylene dichloride. Methyl 
Sulphonyl Methane have less compressibility.  Weight 
granulation by starch paste are not possible for such huge 
weight of tablet. 
Weigh accurately all the ingredient, Glucosamine pass 
through sieve 40, Methyl Sulphonyl Methane # 40 and 
Lactose starch and MCCP pass through sieve 60.  Then active 
and filler mix together.  After this the binding solution is 
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prepared by dissolving the PVP-K 30 into Isopropyl alcohol.  
In the rapid Mixer Granulator the shifted active and filler are 
mixed for five minutes.  Then binding solution added through 
opening duct of Granulator and mix till the smooth granules 
are obtained. 
Remove the wet granules and finally dry in the tray dryer.  
Initially granules are dry on air drying and then start the 
heater and set the temperature at 40 ºC.  The final dried 
granules contains the moisture not more than 1.2 to 1.6 %.  
By IR moisture balance. 
Lubricants are mixed together and pass through sieve 60 and 
lubricate the granules for five to seven minutes in Octagonal 
blander. 
3.2 Compression of tablet. 
Finally dried and lubricated granules are compressed at 
calculated weight by using the D Tooling 27 station Fluid 
Pack Accura (force feeder) at 10-12 RPM.  The punches used 
for compression are buffed by using buffing machine. The 
finally compressed tablet are sorted by using tablet sorting 
machine. All the tablet which are used for in process quality 
control test viz DT, friability, Hardness are destroyed. 
3.3 Tablet Coating. 
Compressed Tablet are coated in the conventional coating 
pan / auto coater.  In Auto coater the appearance of the 
tablet are not the desired quality. All the compressed tablet 
are coated in the conventional coating pan at 6-7 RPM, and 
spay rate is 900 to 1200 ml / 40 minutes.  Insta coat 
readymade coating material are used containing Titanium 
dioxide, HPMC, PEG, Talcum.  Finally coated tablet are 
polished by using Insta coat polishing agent in polishing pan. 
4. EQUIPMENTS AND INSTRUMENTS:  
Tablet Compression Machine by Fluid Pack Accura (force 
feeder), Tablet dissolution apparatus Type II by Electro lab. 
Limited., Electronic Balance Model, Sansui; pH meter by 
Hanna Instrument, Italy; Pfizer Hardness Tester, Roche 
Friability test apparatus; Hot Air Oven by Meta lab Scientific 
Industries, Mumbai. Try dryer, rapid mixer granulator, 
Conventional coating pan. 
 
 
 
 
 
 
 
 
 
 
6. POST COMPRESSION PARAMETERS: 
5.1 Thickness of compressed tablet. 
 
 
 
The thickness of the compress tablets of Glucosamine 1500 
mg & Methyl Sulphonyl Methane 200 mg was determined 
using a Digital Vernier calliper. Ten tablets from each type of 
formulation were used and average values were calculated. It 
is expressed in mm. 
4.2 Hardness 
The resistance of tablets during passing through hopper, 
Blister Cartooning, breakage, under conditions of storage, 
transportation and Handling before usage are directly 
proportional to its hardness. For each formulation, the 
hardness of 6 tablets was determined using the Pfizer 
Hardener Tester and Monsanto hardness tester. The tablet 
was held along its oblong axis in Between the two jaws of the 
tester. At this point, reading should be zero kg/cm2. Then 
constant force was applied by rotating the knob in Monsanto 
tester and in case of Pfizer directly force applied until the 
tablet breakdown in the pieces. The reading in the both 
cases at this point are noted. Electronic Hardener tester by 
Karnavati Lab. Ahmadabad are used to sharp and exact 
reading.  We used both three Tester and found the hardness 
variation 2 kg/cm2 
4.3 Friability Test: 
Friability Test is generally used the measure of tablet 
strength. Roche Friability tester was used for testing the 
friability using. In This test subjects a number of compressed 
tablets to the combined effect of shock abrasion by utilizing 
a circular plastic chamber which revolves at a speed of 25 
revolution per minutes for 4 minutes i.e. 100 rpm, dropping 
the compressed tablets of glucosamine and MSM to a 
distance of 6 inches in each revolution. A sample of 
compressed 20 tablets of was placed in Roche friability 
chamber which was then operated for 100 revolutions i.e. 4 
minutes. The tablets were then de-dusted, and broken tablet 
are removed and reweighed. A loss of less than 1 % in 
weight in generally considered acceptable according to 
Pharmacopeia. Percentage friability (% F) was calculated as 
follows: 
       % Friability = Initial Weight – Final Weight    X    100 
                                                Initial Weight 
NOTE: for Friability test we use only 10 tablet as the 
compressed tablet weight is very high as per various official 
books it is mentioned that only 6 gm tablet are used in 
Friability test. 
4.4 Weight variation test: 
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As per the limitation of Pharmacopeia to find out weight 
variation test, 20 tablets of each type of formulation were 
weighed individually using single pan balance or an 
electronic balance, average weight was calculated and 
individual tablet weight was then compared with average 
value to find the deviation in weight.  
 
 
Specifications for tablets as per Indian Pharmacopeia. 1996. 
S. No. Percentage Deviation Average Weight of Tablet (mg) 
1 10 80 mg or less  
2 7.5 More than 80 mg but less that 250 mg 
3 5 250 or more 
 
4.5 Uniformity of drug content: 
As per the official pharmacopeia’s the randomly sampled 
tablet from the all five compression batches should 
contained the Glucosamine sulphate KCL & Methyl Sulphonyl 
Methane NLT 90 % and NMT 110 % of labelled amount. If 
from the 20 sample tablet at least 18 tablet passed and 2 
tablet fail in the assay calculation then the tablet passed in 
uniformity of drug content.  
4.6 In vitro disintegration time: 
The process of breakdown or convert the tablet into pieces 
or into smaller particles is called as disintegration. The in 
vitro Disintegration time of a tablet was determined using 
disintegration test apparatus as per Indian Pharmacopeia 
specifications.  Place one tablet in each of the 6 tubes of the 
basket. Add a disc to each tube and run the apparatus using 
distilled water maintained at 37° ± 2°C which is similar to 
body temperature. The assembly should be raised and 
lowered between 30 cycles per minute in the 0.1 N HCL or 
Distilled water maintained at 37° ± 2°C. The time in seconds 
taken for complete disintegration of the tablet. 
 In this disintegration test if the tablet are adhere to the 10 # 
sieve then continue the test till all tablet are completely 
disintegrated. 
4.7 In vitro dissolution test: 
Rate of dissolution are studied by using USP type-II 
apparatus having 50 rpm, using 900ml of 0.1 N Hydrochloric 
acid as dissolution solvent. Temperature of the dissolution 
medium was maintained at 37 ± 0.5°C. The sample of 
dissolution medium was withdrawn at every 5 min interval 
and first filtered. The absorbance of filtered solution was 
measured by using Ultra Violet spectrophotometric method 
at mentioned nm specified in official pharmacopeia and 
concentration of the drug was determined from standard 
calibration curve. 
In vitro drug release studies details: 
1. Dissolution test apparatus 
2. 0.1 N HCL as Dissolution medium  
3. 900 ml Dissolution medium volume  
4. 37 ± 0.5°C as std. Temperature  
5. 50 rpm Speed of basket paddle  
6. 5 min sampling intervals  
7. 10 ml volume Sample withdraw 
8.  Absorbance measured as specified in the official books
 
 
5. RESULT AND DISCUSSION: 
5.1 Pre compression Parameter and studies 
S. No. Formulation 
code 
Angle of Repose Bulk density 
(weight/ml) 
Taped Density 
(weight/ml) 
1 C1 34.32±0.70 0.54±0.02 0.47±0.04 
2 C2 32.10±0.56 0.49±0.03 0.45±0.02 
3 C3 31.80±0.63 0.47±0.03 0.42±0.04 
4 C4 29.38±0.45 0.45±0.02 0.39±0.02 
5 C5 28.40±0.69 0.42±0.03 0.38±0.02 
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5.2 Post compression Parameter Studies. 
Formula 
code 
Hardness 
(KG/cm2) 
Friability 
(%) 
Thickness 
(mm) 
Length 
(mm) 
Wt. of Uncoated 
Tablet 
(mg) 
Wt. of film 
coated 
Tablet 
(mg) 
C1 9.8 0.92 7.58 21.02 1790 1825 
C2 8.3 0.88 7.60 210.2 1802 1835 
C3 7.5 0.78 7.66 21.03 1785 1840 
C4 7.2 0.85 7.58 210.1 1799 1822 
C5 6.8 0.91 7.62 210.2 1805 1836 
 
5.3 Post compression Studies: 
Formulation 
code 
Assay of 
Drugs 
(%) 
Disintegration 
time (minutes) 
Uncoated 
Disintegration 
time (minutes) 
Film coated 
Glucosamine 
Dissolution 
(%) 
MSM 
Dissolution 
(%) 
C1 98.66 4.1 to 5.2 7.3 to10.2 96.54 94.45 
C2 98.20 4.5 to 6.3 9.4 to 11.4 94.65 92.50 
C3 98.55 5.2 to 6.4 9.5 to 12.3 93.21 90.32 
C4 98.20 6.3 to 7.2 10.4 to 14.4 90.45 87.84 
C5 98.72 6.2 to 8.2 11.2 to 15.2 88.45 83.65 
 
 
GLUCOSAMINE ASSAY GRAPH 
 
 
METHYL SULPHONYL METHANE ASSAY 
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GLUCOSAMINE DISSOLUTION GRAPH 
 
 
 
METHYL SULPHONYL METHANE DISSOLUTION GRAPH 
 
 
GLUCOSAMINE ASSAY STABILITY DATA FOR 6 MONTS 
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METHYL SULPHONYL METHANE ASSAY STABILITY DATA 6 MONTS 
 
 
TABLET THICKNESS VARATION DATA 
 
 
TABLET HARNDESS VARIATION DATA 
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CONCLUSION 
After the completion of this experiments the result obtained 
and we conclude that development of Glucosamine and MSM 
Tablet formulation by using   PVP k 30 as Binder and cross 
carmillose as disintegrating agent are given the result of 
stable tablet having good hardness, required dissolution and 
well film coated tablet. Some result are mentioned below: 
1. Active drug Glucosamine sulphate and Methyl Sulphonyl 
Methane are stable with different excipient are stable viz 
Starch, Talcum, MCCP, Lactose, Magnesium stearate, cross 
carmillose sodium and PVP K 30. 
2.   Film coated tablet of Glucosamine sulphate 1500 mg 
Methyl Sulphonyl Methane 200 mg FC tablet are successfully 
prepared. 
3.   The flow property of the granules and uniformity of the 
compressed tablet are better in  
Non Aqueous binding with PVP K 30 as compare the 
granules prepared by Aqueous binding with starch Paste. 
4.   The angle of repose of prepared granules are less than 
30º which show the good quality of granules. 
5.   The hardness of compressed tablet by Non Aqueous PVP 
K 30 binding in the rage of 6.8 to 9.8 kg/cm2. 
6.   The Thickness of the prepared tablets by non-aqueous 
wet granulation methods was found between 7.58 mm.  To 
7.66 mm. 
7.   The Friability of the compressed tablet are within the 
range i.e. less than 1%.  
8.   The in vitro disintegration studies are found to be in 4 to 
8 minutes for uncoated tablet and 7 to 15 minutes.   
Formulation C1 showed   in vitro disintegration time is 4.1 to 
5.2 minutes for uncoated tablet and 7.3 to10.2 minutes for 
film coated tablet. 
On the basis of disintegration time formulation C1 which 
facilitate the faster disintegration, sufficient hardness, well 
dissolution, good stability data, and assay, it is better 
formulation   and stable during its shelf life. We conclude 
that film coated tablet are prepared by this Method is stable 
and pass all the test mentioned in the pharmacopeia. 
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